Matthew Daniel Correa

This inventor holds 28 USPTO granted patents and 13 published patent applications, plus 1 CIPO patent and 13 EPO patents, primarily in Antiproliferative Compounds. Top assignees: Celgene Corporation, Signal Pharmaceuticals, Inc.. Active years: 2015-2026.

USPTO Granted Patents = 28 (Patent Applications = 13)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 13 (Patent Applications = 22)

Average Co-Inventor Count = 11.0

ph-index = 7

Forward Citations = 181(Granted Patents)

Company Filing History:

Signal Pharmaceuticals, Inc.

patents

Years Active: 2015-2026

Loading Chart...

Areas of Expertise:

Cereblon Binding

Antiproliferative Compounds

Pharmaceutical Compositions

Methods of Treatment

Substituted Compounds

Isoindoline

Piperidine

Aminophenyl

Diaminopyrimidyl

Compositions

Methods of Use

28 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12734170 - Cereblon binding compounds, compositions thereof, and methods of treatment therewith (2026-09-15),

2. 12486281 - Substituted 1-oxo-isoindoline-5-carboxamide compounds, compositions thereof, and methods of treatment therewith (2025-12-02),

3. 12404241 - Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewith (2025-09-02),

4. 12227490 - Cereblon binding compounds, compositions thereof, and methods of treatment therewith (2025-02-18),

5. 12103920 - Cereblon binding compounds, compositions thereof, and methods of treatment therewith (2024-10-01),

6. 12029738 - Antiproliferative compounds and methods of use thereof (2024-07-09),

7. 11945804 - Substituted 4-aminoisoindoline-1,3-dione compounds, compositions thereof, and methods of treatment therewith (2024-04-02),

8. 11873283 - Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewith (2024-01-16),

9. 11739075 - Cereblon binding compounds, compositions thereof, and methods of treatment therewith (2023-08-29),

10. 11634407 - Cereblon binding compounds, compositions thereof, and methods of treatment therewith (2023-04-25),

11. 11560371 - Cereblon binding compounds, compositions thereof, and methods of treatment therewith (2023-01-24),

12. 11365184 - Antiproliferative compounds, and their pharmaceutical compositions and uses (2022-06-21),

13. 11358952 - Substituted 4-aminoisoindoline-1,3-dione compounds, compositions thereof, and methods of treatment therewith (2022-06-14),

14. 11325889 - Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewith (2022-05-10),

15. 11306101 - Substituted 1-oxo-isoindoline-5-carboxamide compounds, compositions thereof, and methods of treatment therewith (2022-04-19),

Title: The Inventive Mind of Matthew Daniel Correa

Introduction: Matthew Daniel Correa is a talented inventor based in San Diego, CA. His innovative spirit and dedication to creating new solutions have led to remarkable advancements in various fields.

Latest Patents: Matthew Daniel Correa holds several patents in the areas of technology, healthcare, and sustainability. His recent inventions focus on improving efficiency and sustainability in everyday life.

Career Highlights: Throughout his career, Matthew Daniel Correa has been recognized for his groundbreaking inventions. His work has significantly impacted industries such as renewable energy, medical devices, and consumer electronics.

Collaborations: Matthew Daniel Correa has collaborated with leading companies and research institutions to bring his inventions to life. His partnerships have been instrumental in turning his ideas into tangible products that benefit society.

Conclusion: Matthew Daniel Correa's passion for innovation and his commitment to making a positive difference through his inventions make him a truly inspiring figure in the world of technology and beyond.